Takeda Pharmaceutical Co Ltd

CAPTRUST FINANCIAL ADVISORS TAK

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

118,774

Value ($000)

1,852

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	1,852	0.0%	118,774	12/31/2025
2025 Q3	11/19/2025	602	0.0%	41,104	9/30/2025
2025 Q2	8/15/2025	594	0.0%	38,440	6/30/2025
2025 Q1	5/15/2025	539	0.0%	36,251	3/31/2025
2024 Q4	2/14/2025	231	0.0%	17,434	12/31/2024
2024 Q3	11/14/2024	343	0.0%	24,136	9/30/2024
2024 Q2	8/15/2024	338	0.0%	26,102	6/30/2024
2024 Q1	5/15/2024	529	0.0%	38,102	3/31/2024
2023 Q4	2/14/2024	804	0.0%	56,327	12/31/2023
2023 Q3	11/15/2023	919	0.0%	59,413	9/30/2023
2023 Q2	8/15/2023	512	0.0%	32,564	6/30/2023
2023 Q1	5/15/2023	518	0.0%	31,425	3/31/2023
2022 Q4	2/15/2023	570	0.0%	36,531	12/31/2022
2022 Q3	11/16/2022	207	0.0%	15,958	9/30/2022
2022 Q2	8/23/2022	174	0.0%	12,405	6/30/2022
2022 Q1	5/16/2022	121	0.0%	8,434	3/31/2022
2021 Q4	2/14/2022	213	0.0%	15,601	12/31/2021
2021 Q3	11/16/2021	126	0.0%	7,720	9/30/2021
2021 Q2	8/16/2021	148	0.0%	8,804	6/30/2021
2021 Q1	5/17/2021	148	0.0%	8,107	3/31/2021
2020 Q4	2/16/2021	111	0.0%	6,122	12/31/2020
2020 Q3	11/17/2020	74	0.0%	4,204	9/30/2020
2020 Q2	8/14/2020	54	0.0%	3,052	6/30/2020